Test Overview
Test Methodology

Chemiluminometric Immunoassay

Test Usage

May be useful for predicting early recurrence of disease in women who have been treated for carcinoma of the breast. FDA approved for serial testing in women with prior stage II or III breast cancer who are clinically free of disease. This test should be used in conjunction with other clinical methods used for the early detection of recurrence.

Reference Range *

Reference values have not been established for patients that are less than 18 years of age. Female: < or = 38 U/mL; Male: < or = 38 U/mL (use not defined).

Test Limitations

Not useful as a screening test for carcinoma of the breast. For research use only in male patients.

Test Details
Days Set Up
Monday - Friday
Analytic Time

2 - 3 days

Soft Order Code
C2729
MiChart Code
Cancer Antigen 27.29
Synonyms
  • BREAST CARCINOMA-ASSOC ANTIGEN
Laboratory
Sendout
Reference Laboratory
Mayo C2729 (81413)
Section
Special Testing
Specimen Requirements
Collection Instructions

Collect specimen in a red top or SST tube. Centrifuge within 2 hours of collection, aliquot serum into a plastic vial and freeze.

Yellow Top Tube
Normal Volume
0.5 ml serum
Minimum Volume
0.25 ml serum
Additional Information

Test sent to Mayo Medical Laboratories.

Billing
CPT Code
86300
Fee Code
32065
LOINC
17842-6
NY State Approved
No